Literature DB >> 8705220

Infection after transrectal core biopsies of the prostate--risk factors and antibiotic prophylaxis.

G Aus1, G Ahlgren, S Bergdahl, J Hugosson.   

Abstract

OBJECTIVE: To compare the infection rate between different durations of antibiotic prophylaxis after transrectal core biopsy and to evaluate the impact of possible risk factors. PATIENTS AND METHODS: The study comprised 491 patients who underwent transrectal core biopsies of the prostate and who were randomized to receive 400 mg of norfloxacin twice daily for one day or one week.
RESULTS: Patients receiving prophylaxis for one week had a significantly lower rate of infection (4.9%) compared to patients who received only two tablets (11%; P < 0.05). The most pronounced effect was seen in those patients with risk factors (e.g. an indwelling catheter, a former history of urinary tract infection, diabetes or prostatitis) in whom the infection rate was reduced from 17.9% to 3.3% (P < 0.02), and febrile infections from 9.5% to 1.1% (P < 0.02).
CONCLUSIONS: Some factors have a clear impact on the risk of developing an infection after transrectal core biopsy. Prophylaxis for one week with norfloxacin is an effective way to minimize these infections.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8705220     DOI: 10.1046/j.1464-410x.1996.01014.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  22 in total

Review 1.  Interventions for chronic abacterial prostatitis.

Authors:  C McNaughton; R Mac Donald; T Wilt
Journal:  Cochrane Database Syst Rev       Date:  2001

2.  CUA guidelines on prostate biopsy methodology.

Authors:  Assaad El-Hakim; Sabri Moussa
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

3.  Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary?

Authors:  Jordi Puig; Anna Darnell; Patricia Bermúdez; Antoni Malet; Guadalupe Serrate; Marisa Baré; Joan Prats
Journal:  Eur Radiol       Date:  2006-01-04       Impact factor: 5.315

4.  Time of administration of a single dose of oral levofloxacin and its effect in infectious complications from transrectal prostate biopsy.

Authors:  Athanasios N Argyropoulos; Konstantinos Doumas; Antonios Farmakis; Ioannis Liakatas; Ioannis Gkialas; Michael Lykourinas
Journal:  Int Urol Nephrol       Date:  2007-01-04       Impact factor: 2.370

5.  Catastrophic sepsis and hemorrhage following transrectal ultrasound guided prostate biopsies.

Authors:  Paul Toren; Roshan Razik; John Trachtenberg
Journal:  Can Urol Assoc J       Date:  2010-02       Impact factor: 1.862

6.  The preventive effect of tamsulosin on voiding dysfunction after prostate biopsy: a prospective, open-label, observational study.

Authors:  Seung Jun Chung; Seung Il Jung; Ji Won Ryu; Eu Chang Hwang; Dong Deuk Kwon; Kwangsung Park; Jin Woong Kim
Journal:  Int Urol Nephrol       Date:  2015-03-27       Impact factor: 2.370

Review 7.  [Prophylaxis of infectious complications following prostate biopsy].

Authors:  A Pilatz; G Lüdecke; F Wagenlehner
Journal:  Urologe A       Date:  2017-06       Impact factor: 0.639

8.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

9.  Novel diagnostic biomarkers for prostate cancer.

Authors:  Chikezie O Madu; Yi Lu
Journal:  J Cancer       Date:  2010-10-06       Impact factor: 4.207

10.  Simple use of the suppository type povidone-iodine can prevent infectious complications in transrectal ultrasound-guided prostate biopsy.

Authors:  Dong Soo Park; Jong Jin Oh; Jin Ha Lee; Woong Ki Jang; Young Kwon Hong; Sung Keun Hong
Journal:  Adv Urol       Date:  2009-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.